First Trust Advisors’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
First Trust Advisors's PBYI Position: Q3 2026 in Review
First Trust Advisors increased its Puma Biotechnology (PBYI) stake by 33% in Q3 2026, buying an estimated $373K and bringing the position to 172,627 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2087.
First Trust Advisors first reported a position in PBYI in Q3 2017 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- First Trust Advisors held 172,627 shares of Puma Biotechnology worth $1.71M as of Q3 2026.
- First Trust Advisors bought 42,421 Puma Biotechnology shares in Q3 2026, an estimated $373K.
- Puma Biotechnology made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #2087 holding.
- First Trust Advisors first reported a position in Puma Biotechnology in Q3 2017 and has held it in 7 quarters since.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.